Acquisition of Modella AI (oncology multimodal foundation models and agents)
Research partnerships Announcement
Disclosed: Verified: Partners: Modella AI
AstraZeneca bought Modella AI, following a 2025 collaboration, to bring its pathology foundation models and AI agents in-house for oncology R&D, including biomarker and targeted-therapy work.